SmarterDividends

BBIO vs LLY: Which Is the Better Dividend Stock?

As of Nov 22, 2026, LLY (Eli Lilly and Company) screens as the stronger dividend stock, winning 3 of 3 head-to-head metrics. LLY offers the higher yield at 0.51%, LLY has the higher dividend-safety score.

Key facts: BBIO vs LLY

Data as of · Source: SmarterDividends data

  • As of Nov 22, 2026, Eli Lilly and Company (LLY) has the higher forward dividend yield at 0.51%, versus 0.00% for BridgeBio Pharma, Inc. (BBIO).
  • By SmarterDividends' count as of Nov 22, 2026, BBIO has raised its dividend for 0 consecutive years and LLY for 11.
Cite this page

SmarterDividends, "BBIO vs LLY: Dividend Yield, Safety & Value Compared," updated Nov 22, 2026, https://smarterdividends.com/compare/bbio-vs-lly

MetricBBIOLLY
Forward yield0.00%0.51%
Annual dividend$0.00$6.92
Payout ratio—22%
Years of growth0 yr11 yr
5-yr dividend growth—15.2%
5-yr total return—388%
Dividend safety score—94 (A)
Fair value estimate—$804.91
Upside to fair value—-40%
Frequency—quarterly
Market cap$14.8B$1.2T
P/E ratio—43.7

Higher yield

LLY

0.51%

Safer dividend

LLY

Grade A

Faster growth

LLY

15.2%

BBIO vs LLY FAQ

Is BBIO or LLY a better dividend stock?

On the data, LLY wins more head-to-head categories (3 vs 0). LLY offers the higher yield (0.51%), while LLY has the stronger dividend-safety score. The right pick depends on whether you prioritise income, safety or value.

Which has a higher dividend yield, BBIO or LLY?

LLY has the higher forward dividend yield at 0.51%, versus 0.00% for BBIO.

Is BBIO or LLY safer?

Compare each stock's payout ratio, growth streak and cut history on its detail page to judge safety.

See more dividend stock comparisons · data refreshes daily · for informational purposes only, not investment advice.